Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

Documents similaires

• Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
  par: G. Gulli
  Publié: (2013-05-01)
• Incidence of diabetes following ramipril or rosiglitazone withdrawal
  par: Holman, R, et autres
  Publié: (2011)
• Incidence of diabetes following ramipril or rosiglitazone withdrawal.
  par: Investigators, D
  Publié: (2011)
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
  par: Gerstein, H, et autres
  Publié: (2006)
• MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
  par: Paul Valensi MD, et autres
  Publié: (2024-06-01)